Spherix
AIkido Labs Inc. is a biotechnology development company based in New York, NY, with a focus on developing a diverse portfolio of early and mid-stage small-molecule anti-cancer therapeutics. The company's platform includes patented technology from leading universities and researchers, with a mission to innovate through strong partnerships with renowned institutions like The University of Texas and Wake Forest University.
Specializing in the treatment of prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia (ALL), AIkido Labs Inc. holds an Exclusive World-Wide License to a Broad Spectrum Antiviral Drug Platform, including Coronavirus, from the University of Maryland Baltimore. Their pipeline of therapeutics has shown promising preclinical results for prostate and pancreatic cancer treatments.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.


